The rice blast disease, caused by a pathogenic fungus Pyricularia oryzae (teleomorph: Magnaporthe grisea), is one of the most serious and damaging diseases in rice production. When attaching on the hard epidermis of rice, the fungus forms a cellular structure called an appressorium at the tip of germ tube 1) and synthesizes fungal melanin through its pentaketide pathway. 2) Synthesized melanin molecules are arranged into layer structures between the cell wall and cell membrane of the appressorium.
3) The layer structures of melanin ensure the generation of an osmotic pressure as high as 8.0 MPa inside the appressorium to puncture mechanically the hard epidermis of rice. Thus, melanization of the appressorium is essential for pathogenicity, and the enzymes involved in the melanin biosynthesis are good targets for developing control agents against rice blast disease. 4, 5) The melanin biosynthesis pathway is composed of the initial step to fuse five isoprenyl units, two sets of alternating reduction and dehydration steps, and the final step to polymerize 1,8-di-hydroxynaphtalene into melanin.
2) To date, two types of melanin biosynthesis inhibitors (MBI) have been developed and used in the field: Tricyclazole, 6) pyroquilon, 7) and phthalide 8) inhibit the enzymes in the reduction step 9) (MBI-Reductase, MBI-R) and carpropamid (see below), diclocymet 10) and fenoxanil 11) (MBI-Dehydratase, MBI-D) interfere with the enzymes in the dehydration step.
Carpropamid ((1RS,3SR)-2,2-dichloro-N-[(R)-1-(4-chlorophenyl)ethyl]-1-ethyl-3-methylcyclopropanecarboxamide) is a potent control agent against the pathogenic fungus, 4, 5) and its primary target is scytalone dehydratase (SDH; EC 4. 2. 1. 94) catalyzing the dehydration step in the melanin biosynthesis. 12, 13) The enzyme catalyzes the conversions of scytalone to 1,3,8-trihydroxynaphthalene and vermelone to 1,8-dihydroxynaphthalene. 14) Through biochemical studies, carpropamid is known to work as a tight-binding inhibitor of SDH.
13) The dissociation constant of carpropamid (K i ) was determined to be 0.14 nM and was about 2 Â 10 5 times smaller than that for the substrate, scytalone (K m ; 31 M).
13) The tight-binding inhibition is caused by a number of hydrogen bonds and van der Waals intery To whom correspondence should be addressed. Tel:+81-45-503-9488; Fax:+81-45-503-9489; E-mail: yamaism@postman.riken.go.jp actions between SDH and carpropamid, involving hydration water molecules and residues in the activesite pocket of SDH, as revealed by high-resolution crystal structure analyses of SDH-carpropamid complexes 15, 16) (Fig. 1 ). Carpropamid has been used as one of the most effective fungicides for rice blast fungus since 1998. However, in 2001, isolates of the rice blast fungus with reduced sensitivity to this fungicide and diclocymet appeared in Saga Prefecture in Japan. 17, 18) The resistant isolates were shown to be as virulent as the wild-type strains. It has been believed that resistant strains may not appear against fungicides inhibiting secondary metabolism like the fungal melanin biosynthetic pathway. Thus, the appearance of the MBI-resistant isolates was rather unexpected. Molecular biological researches suggested that the reduced sensitivity to carpropamid was caused by a point mutation resulting in Val75Met of SDH. 19) In this study, we analyzed the effects of Val75Met mutation on the enzymatic activity and inhibition by carpropamid isomers using a recombinant Val75Met-SDH enzyme. Here we present the details of the experimental results and discuss the possible structural mechanisms for reduction of the inhibitor binding in retaining the enzymatic activity, based on these results and our previous crystal structure analysis.
15)

Materials and Methods
Construction of over-expression system and preparation of recombinant Val75Met-SDH. Carpropamid-resistant isolates 20) provided by the Zennoh Agricultural R&D Center were originally isolated in Saga Prefecture. Sequencing of the SDH genes of five carpropamidresistant isolates confirmed that there was only one point mutation (GTG-to-ATG) that caused the amino acid change (Val75Met) in the open-reading-frame of the SDH gene. Then, the GTG-to-ATG mutation for Val75Met change was introduced into the SDH cDNA on a plasmid, pKF-SDH, by site-directed mutagenesis with use of the Mutan-Express Km kit (Takara Shuzo Co., Ltd., Kyoto, Japan). An oligonucleotide of 5 0 -GTCTCGAGCAAGCAGATGCTGGGCGACC-3 0 was used as a primer. Prior to the mutagenesis, the pKF-SDH plasmid was prepared by ligating the 0.6-kb XbaIBamHI fragment of the SDH cDNA from a SDH expression plasmid, pET-SDH, 21) with a pKF18k plasmid (Takara Shuzo, Kyoto, Japan) digested by XbaI and BamHI.
Two types of expression vectors were constructed: one includes the Val75Met-SDH variant with an Nterminal 11-residues histidine-tag (Met-Arg-Gly-SerHis-His-His-His-His-His-Ser) (pET-H6V75MSDH) and another without the tag (pET-V75MSDH). The pET-H6V75MSDH vector was constructed by replacing the SDH cDNA (0.52-kb NcoI-BamHI fragment) on an overexpression vector, pET-H6SDH, by the Val75Met-SDH cDNA in the mutated pKF-SDH. The pET-H6SDH vector can overexpress wild-type SDH with the histidine-tag in E. coli BL21(DE3)pLysS strain (Novagen Inc., Madison, WI) under the control of a T7lac promoter. The vector was constructed as follows. At the first, a vector, pKF-H6SDH, was constructed by introducing a histidine-tag sequence into the SDH cDNA on pKF-SDH at just the upstream of the initiation codon with use of the Mutan-Express Km kit and an oligonucleotide primer (5 0 -GTTTAACTTTAAGAAG-GAGATATACCATGAGAGGATCGCATCACCATCA-CCATCACTCCATGGGTTCGCAAGTTCAAAAGAG-CG-3 0 ; the histidine tag sequence is underlined). Then, the pET-H6SDH vector was made by cloning the 0.6-kb XbaI-BamHI fragment from pKF-H6SDH into the pET19b plasmid (Novagen Inc., Madison, WI). The pET-V75MSDH vector was constructed by cloning the Val75Met-SDH cDNA into pET19b. Throughout the gene manipulation, introduced mutations were confirmed by DNA sequencing.
Either vector was used to transform the E. coli BL21(DE3) pLysS strain, and overexpressed Val75Met-SDH under the control of a T7lac promoter. The recombinant enzyme was purified using a Ni-NTA affinity column (Qiagen K. K., Japan) in the presence of 15% (w/v) glycerol to stabilize the conformation of purified enzyme. After the purification, imidazole, used for eluting the enzyme, was removed by gel filtration. Val75Met-SDH without the His-tag was prepared as described previously. 13) Measurement of enzymatic kinetics of Val75Met-SDH. Scytalone was prepared from the cultured broth of carpropamid-treated P. oryzae P2 strain grown in the YGPCa medium as described previously. 12) Carpropamid was prepared based on the patent description. 22) Because carpropamid has three asymmetric carbon atoms (Fig. 1) , eight stereo-isomers are possible. In this assay, we used six compounds of carpropamid.
Four compounds, KTU3616A, KTU3616B, KTU3615A, and KTU3615B, contained purified isomers as shown in Fig. 1(A) . The NTN33853 compound was an equi-molar mixture of the above four isomers. The NTN36945 compound was an equi-molar mixture of the other four isomers. Another SDH- 23) was also used as a reference. The enzymatic activities of Val75Met-SDH at 303 K were measured in 50 mM PIPES buffer (pH 7.0) by monitoring the absorption at 282, 352 and 360 nm with an UV-recording spectrophotometer UV-2500PC (Shimadzu, Kyoto, Japan). The catalytic conversion of scytalone to 1,3,8-trihydroxynaphthalene causes a prominent decrease in absorption at 282 nm and increases at 352 and 360 nm. The reaction rates were calculated from the tangents of the progress curves at the initial stage of the reaction under assuming difference molar extinction coefficients Á" 282 of À8:0 mM À1 cm À1 , Á" 352 of 5.9 mM À1 cm À1 and Á" 360 of 4.0 mM À1 cm À1 at the three wavelength. Dimethylsulfoxide of 0.5% (v/v) was added to the sample solutions to dissolve scytalone and inhibitors in all measurements.
Parameters characterizing enzymatic activity of Val75Met-SDH were analyzed by the Michaelis equation;
where v is the velocity of catalysis, V max is the maximum velocity, S is the concentration of substrate, and K m is the Michaelis constant. Inhibitor constant (K i ) values of carpropamid isomers were determined by fitting the enzymatic activity data to the following equation assuming competitive inhibition;
where I is the concentration of the inhibitor molecules.
Val75Met Variant of Scytalone Dehydratase
Results
Enzymatic activity of Val75Met-SDH The GTG-to-ATG mutation corresponding to the Val75Met change is introduced into the SDH cDNA by the site-directed mutagenesis. The Val75Met-SDH is overexpressed in E. coli with or without an N-terminal histidine-tag and purified. When cultured in a scale of 200 ml, the overexpression system and the purification procedures yielded mutant proteins of 15 mg.
The time-courses of the enzymatic reactions of Val75Met-SDH with or without the N-terminal histidine-tag are well approximated by the Michaelis equation in the substrate concentration range used (5 M to 100 M). The determined kinetic parameters are compared with those of the wild-type SDH in Table 1 . The affinity of the variant to scytalone is similar to that of the wild-type enzyme, 13) but the turn-over rate is ca. half of that of the wild-type. Despite the reduced activity, Val75Met-SDH still has a significant level of enzymatic activity probably ensuring melanin biosynthesis in the pentaketide pathway. Because the enzymatic activities of the variants are independent of the presence and the absence of the histidine-tag (Table 1) , the overall structures of the two variants are probably quite similar.
Inhibition of Val75Met-SDH by carpropamid and the isomers
Because carpropamid has three asymmetric carbon atoms (Fig. 1A) , eight diastereomers can exist. Commercially available carpropamid compound actually contains four isomers, KTU3616A, KTU3616B, KTU3615A, and KTU3615B. We first analyzed inhibition of Val75Met-SDH by carpropamid-isomers and another SDH-inhibitor BFS (see Materials and Methods for structure) at the concentrations of 1500 nM in the reaction mixtures containing 0.6 nM Val75Met-SDH and 50 M scytalone (Fig. 2) . KTU3616A, KTU3616B, KTU3615A, KTU3615B, NTN33853, NTN36945, and BFS inhibited Val75Met-SDH significantly in this condition, indicating that KTU3616A, KTU3616B, KTU3615A, KTU3615B, some component of NTN36945, and BFS have considerable inhibitory activity on Val75Met-SDH. However, none of the compounds inhibit Val75Met-SDH at near the concentration of the enzyme. Thus, all the isomers and BFS are not tight-binding inhibitors for Val75Met-SDH under the assay conditions used.
The Lineweaver-Burk plots of inhibition kinetics indicate that the four carpropamid isomers, KTU3616A, KTU3616B, KTU3615A, and KTU3615B, work as competitive inhibitors in the presence of 0.6 nM Val75Met-SDH and 10 to 300 M scytalone. The K i values listed in Table 2 indicate that the isomers inhibit Val75Met-SDH with reduced strength compared to the wild-type SDH. Only one isomer KTU3616B binds strongly to the enzyme, and KTU3616A does lesser extent. The inhibition rates of the rest two are more than 100-fold lower than that of KTU3616B. The K i value of KTU3616B suggests that it is still an effective inhibitor for the variant enzyme under the experimental conditions in vitro, although the inhibition for the variant enzyme is 230-times reduced from that for the wild-type enzyme. Among the four isomers, the order of the inhibition-strength for the variant enzyme is KTU3616B ) KTU3616A > KTU3615A > KTU3615B.
Discussion
In this study, we confirmed the point mutation in SDH-gene of the carpropamid-resistant strain and constructed overexpression system of the Val75Met variant enzyme in E. coli. We determined the reaction kinetics and the affinity to carpropamid isomers through in vitro assays. Here, we discuss the structural mechanism to cause the resistance based on the kinetics data and the crystal structure of the wild type SDH-carpropamid complex.
The Val75Met variant still retains a significant level of enzymatic activity probably enough for working in the pentaketide pathway of the fungal melanin biosynthesis in the appressorium. While the turn-over rate of the variant enzyme is reduced from that of the wild type, the affinity of scytalone to the enzyme is almost the same with that of the wild type ( Table 1 ). The inhibition assays revealed that KTU3616B still inhibits efficiently the Val75Met variant as a competitive inhibitor ( Fig. 2 and Table 2 ). Among the compounds containing pure isomers (Table 2) , the order of the strength in the inhibition for the variant enzyme has similar tendencies with that for the wild type.
22) The interaction modes found in the SDH-carpropamid (KTU3616B) complex likely account for the relatively weak affinities of the three isomers (KTU3616A, KTU3615A, and KTU3615B) to SDH as discussed previously. 22) Thus, these results suggest that the structure of the active-site pocket of Val75Met closely resembles that in the wild type.
In the crystal structure of the SDH-carpropamid (KTU3616B) complex, 13) Val75 is located at the tip of the C-helix of SDH and forms the mouth part of the active site pocket. Its side chain tightly contacts with the chloro-phenyl ring of carpropamid so that its main chain conformation is out of the standard conformation 15) ( Fig. 1) . In Val75Met, the side chain of Met75 probably protrudes into the pocket (Fig. 1) . When the conformation of Met75 is rigid, the side chain likely hinders the association of the substrate to and the dissociation of the product from the active-site pocket. However, the K m values are equal between the wild-type and the variant enzymes (Table 1) , and carpropamid isomers still bind to the variant enzyme ( Fig. 2 and Table 2 ). To explain these results, the side chain of Met75 is expected to have large positional fluctuation enabling the access of substrate or inhibitor molecules to the cavity from bulk solvent. In the crystal structure, the room for the Met75 side chain is actually enough large for rotating freely on its C-C bond (Fig. 1) .
In the dehydration reaction by SDH, substrate scytalone must be located to interact precisely with the catalytic residue His85. At least one hydration water molecule ('Wat1' in Fig. 1 ) and residues forming the active-site pocket must contribute to the stabilization of the transition state. 24, 25) Because the 75-th residue is located at the opposite side to the catalytic residue in the pocket, the Val75Met mutation seems to have little direct influence on the catalytic reaction. However, the turn-over rate (k cat ) of the Val75Met variant is reduced from those of wild type (Table 1) . It has been pointed that hydrophobic Val75 and Met69 residues in the wildtype enzyme have a role to enhance indirectly the dehydration reaction. 26) Thus, the mutation makes it slightly difficult to locate and/or orient the substrate molecule against the catalytic residue. In addition, the reduction in affinities of isomers to the variant (Table 2) implies that the accessibility and/or the residence of the isomers in the active site are decreased by the mutation. This result may also be explained by the positional fluctuation of the Met75 side chain weakening the tight contact between inhibitor molecules and residues of the active-site pocket. In this regard, it is interesting that various types of inhibitor molecules show reduced affinities to the Val75Ala variant by 10-70-fold lower than to the wild-type enzyme. 26) Thus, the isopropyl group of Val75 may be the most suitable side chain in the size for realizing efficient molecular interactions between substrate/inhibitor and SDH.
Despite the fact that carpropamid works as a tightbinding inhibitor for the wild-type and as a relatively strong competitive inhibitor for the variant SDH in in vitro assays, why does it exert an antifungal efficacy only for wild-type strain in the practical use in field? The inhibition event is quite concentration dependent even in the case of tight-binding inhibitor. Because the concentrations of carpropamid and SDH molecules in the cytoplasm of the appressorium are not known, it is difficult to answer to the question. However, when the number of carpropamid molecules transported into the appressorium is very small in comparison with that of SDH, the differences in K i values of carpropamid against the wild-type and the variant enzymes may be critically important for inhibition. This possibility may be examined by an in vivo experiment using higher concentrations of carpropamid solution against the resistant strain.
Despite a long-term application of inhibitors for reductase in the melanin biosynthesis in fields, [6] [7] [8] appearance of rice blast fungus resistant to the inhibitors has not yet been reported. The present appearance of the c Inhibitor constant value of KTU3616B for the wild-type enzyme was refined further after the previous report. 13) carpropamid-resistant strain, however, indicates that a resistant strain against fungicides inhibiting secondary metabolism can appear in the presence of selective pressure. It is not known the reason why resistant strains to reductase inhibitors do not appear and to dehydratase inhibitors appear. Recent progress in three-dimensional structural analyses of enzymes in the melanin biosynthesis may provide clues to understand this phenomenon at molecular level. Now, the crystallization trials of the variant enzyme have been started. A crystal structure at an atomic resolution must explain the structural mechanism of the carpropamid-resistance and provide clues for designing novel chemicals against the variant enzyme. Then, the present biochemical results have critical importance to analyze the structure-function relationship of the variant enzyme.
